References
- Wong SC, Au AK, Chen H, et al. Transmission of Omicron (B.1.1.529) – SARS-CoV-2 variant of concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19. Lancet Reg Health West Pac. 2022;18:100360.
- Madhi SA, Kwatra G, Myers JE, et al. Population immunity and Covid-19 severity with Omicron variant in South Africa. N Engl J Med. 2022;386:1314–1326.
- Cheng VC, Fung KS, Siu GK, et al. Nosocomial outbreak of COVID-19 by possible airborne transmission leading to a superspreading event. Clin Infect Dis. 2021;73:e1356–e1364.
- Lu L, Mok BW, Chen LL, et al. Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or coronavac vaccine recipients. Clin Infect Dis. 2021. doi:10.1093/cid/ciab1041:ciab1041.
- Chen LL, Chua GT, Lu L, et al. Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine. Emerg Microbes Infect. 2022: 1–17. doi:10.1080/22221751.2022.2035195.
- Cheng VC, Ip JD, Chu AW, et al. Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak. Clin Infect Dis. 2022. doi:10.1093/cid/ciac203:ciac203.
- Cai J, Deng X, Yang J, et al. Modeling transmission of SARS-CoV-2 Omicron in China. Nat Med. 2022;28:1468–1475.
- Altarawneh HN, Chemaitelly H, Hasan MR, et al. Protection against the Omicron variant from previous SARS-CoV-2 infection. N Engl J Med. 2022;386:1288–1290.
- Gray G, Collie S, Goga A, et al. Effectiveness of Ad26.COV2.S and BNT162b2 vaccines against Omicron variant in South Africa. N Engl J Med. 2022;386:2243–2245.
- Chen LL, Abdullah SM, Chan WM, et al. Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong. Nat Commun. 2022;13:3618.
- Lu L, Chen LL, Zhang RR, et al. Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines. EBioMedicine. 2022;79:103986.
- Clarke KEN, Jones JM, Deng Y, et al. Seroprevalence of infection-induced SARS-CoV-2 antibodies – United States, September 2021–February 2022. Morb Mortal Wkly Rep. 2022;71:606–608.
- Wang X, Lam JY, Wong WM, et al. Accurate diagnosis of COVID-19 by a novel immunogenic secreted SARS-CoV-2 orf8 protein. mBio. 2020: 11: e02431-20.
- Lung DC, Sridhar S, Yuen KY. 高築屏障護民康 復常無懼浪接浪. Ming Pao. [cited 2022 May 25]. Available from: https://mmingpaocom/pns/%e8%a7%80%e9%bb%9e/article/20220520/s00012/1652984046769/%e9%be%8d%e6%8c%af%e9%82%a6-%e8%96%9b%e9%81%94-%e8%a2%81%e5%9c%8b%e5%8b%87-%e9%ab%98%e7%af%89%e5%b1%8f%e9%9a%9c%e8%ad%b7%e6%b0%91%e5%ba%b7-%e5%be%a9%e5%b8%b8%e7%84%a1%e6%87%bc%e6%b5%aa%e6%8e%a5%e6%b5%aa.
- Saure D, O'Ryan M, Torres JP, et al. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study. Lancet Infect Dis. 2022;22:56–63.